COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,740 Articles (22,502 medRxiv, 8,238 bioRxiv)

Most recent first Previous |  Page 2020: Articles 20191-20200  | Next

A nanobody-functionalized organic electrochemical transistor for the rapid detection of SARS-CoV-2 or MERS antigens at the physical limit
Guo, K., Wustoni, S., Koklu, A., Diaz-Galicia, E., Moser, M., Hama, A., Alqahtani, A. A., Nazir Ahmad, A., Alhamlan, F. S., McCulloch, I., Arold, S. T., Grünberg, R., Inal, S.
10.1101/2020.11.12.20228874 — Posted: 2020-11-13
Longevity of seropositivity and neutralizing titers among SARS-CoV-2 infected individuals after 4 months from baseline: a population-based study in the province of Trento
Stefanelli, P., Bella, A., Fedele, G., Fiore, S., Pancheri, S., Benedetti, E., Fabiani, C., Leone, P., Vacca, P., Schiavoni, I., Neri, A., Carannante, A., Simmaco, M., Santino, I., Zuccali, M. G., Bizzarri, G., Magnoni, R., Benetollo, P. P., Brusaferro, S., Rezza, G., Ferro, A.
10.1101/2020.11.11.20229062 — Posted: 2020-11-13
Secondary Household Covid-19 Transmission Modelling of Students Returning Home from University
Harper, P. R., Moore, J. W., Woolley, T. E.
10.1101/2020.11.11.20229559 — Posted: 2020-11-13
A computational analysis on Covid-19 transmission raises imuuno-epidemiology concerns.
Kyriakopoulos, A., Zhao, S.
10.1101/2020.11.11.20229641 — Posted: 2020-11-13
Corticosteroids are associated with increased survival in elderly presenting severe SARS-Cov2 infection
Gallay, L., Tran, V.-T., Perrodeau, E., Vignier, N., Mahevas, M., Bisio, F., Forestier, E., Lescure, X.
10.1101/2020.11.10.20226886 — Posted: 2020-11-13
Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand
Huang, S., Wood, T., Jelley, L., Jennings, T., Jeffries, S., Daniels, K., Nesdale, A., Dowell, T., Turner, N., Campbell-Stokes, P., Balm, M., Dobinson, H. C., Grant, C. C., James, S., Aminisani, N., Ralston, J., Gunn, W., Bucacao, J., Danielewicz, J., Moncrieff, T., McNeill, A., Lopez, L., Waite, B., Kiedrzynski, T., Schrader, H., Gray, R., Cook, K., Currin, D., Engelbrecht, C., Tapurau, W., Emmerton, L., Martin, M., Baker, M. G., Taylor, S., Trenholme, A., Wong, C., Lawrence, S., McArthur, C., Stanley, A., Roberts, S., Ranama, F., Bennett, J., Mansell, C., Dilcher, M., Werno, A., Grant, J., van der Linden, A., Youngblood, B., Thomas, P. G., Webby, R. J.
10.1101/2020.11.11.20228692 — Posted: 2020-11-13
Using Real World Data to Understand HIV and COVID-19 in the U.S.A. and Spain: Characterizing Co-Infected Patients Across the Care Cascade
Kohler, J., Kostka, K. M., Makadia, R., Paredes, R., Duarte-Salles, T., Duvall, S. L., Matheny, M., Lynch, K. E., Cheng, A., Golozar, A., Lane, J. C. E., Sena, A. G., Rijnbeek, P. J., Morales, D. R., Ryan, P. B., Reich, C. G., Siberry, G., Prieto-Alhambra, D.
10.1101/2020.11.10.20229401 — Posted: 2020-11-13
Universal Health Coverage and COVID-19 Pandemic: A Bangladesh Perspective
Ferdous, M. Z., Islam, U. S.
10.1101/2020.11.11.20229526 — Posted: 2020-11-13
Impact of COVID-19 on the outreach strategy of cancer social service agencies in Singapore: A pre-post analysis with Facebook data
Tan, K. E., Sesagiri Raamkumar, A., Wee, H. L.
10.1101/2020.11.11.20229740 — Posted: 2020-11-13
Addressing a complicated problem: can COVID-19 asymptomatic cases be detected and epidemics stopped, when testing is limited and the location of such cases unknown?
Rivas, A. L., Hoogesteyn, A. L., Hittner, J., Fasina, F. O., van Regenmortel, M. H. V.
10.1101/2020.11.10.20223495 — Posted: 2020-11-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).